PPT-C . difficile and CRE infection: Tackling the Superbugs

Kevin W Garey PharmD MS FASHP Professor and Chair Department of Pharmacy Practice and Translational Research Update on progress of citywide stewardship projects Focus on a better understanding of antimicrobial resistance in the Houston area. B Ve 1 K Sch ec 1 N D or dj ic E A H Dj amshi ur V Sh um R Br ill 2 1 Loc he M rt S pace Sy st em s Co 11 11 L he d rt in Way nnyv le C orni a A 9 tth an te com ni k dj evi lmc kei r sc reck lmc oc 2 J se St Uni si De rt nt of Mec anic l 001 0 025mm CRE ebax 0002 0051mm TH UG TH EB ALLOON V EW F D ILATION AN D TISS UE RE SPONS CRE in64258ated to 135mm CRE in64258ated to 15mm CRE in64258ated to 12mm Clinical images courtesy of A Kruse MD Aarhus University Hospital Denmark Sources Be Clostridium . difficile. Infection (CDI). for Non-Clinical . Healthcare Workers. HAI Prevention Strategies Subcommittee. August 2011. These presentation slide sets were developed by the Prevention Strategies Subcommittee of the Arizona Healthcare-Associated Infection (HAI) Advisory Committee. Their works was guided by the best available evidence at the time this document was created. The objectives of the PSS are directed at providing access to additional resources for healthcare facilities, creating a repository of informational anc constructing a toolkit of strategies to assist facilities in preventing healthcare-associated infections.. What it takes to be a great tackler. 1. You must have CONFIDENCE. You need VISION. You must move your FEET. You need to understand ANGLES. You must have TOUGHNESS. Tackling Fundamentals. Most common mistakes. National Healthcare Sales Director. Infection Control Specialist. Clorox HealthCare. To use or not to use Sporicidal agents everywhere?. Disclaimer. Disclosures. : . Employee of Clorox . HealthCare ™ . OHA HEN 2.0. C. Difficile Infection (CDI). AIM. Primary Drivers. Secondary Drivers. Change Ideas. Reduce CDI by 40%. Antimicrobial Stewardship. Audit antimicrobial use prospectively and provide direct feedback to the provider. Infection. Serin. a Tart, PharmD. Antimicrobial Stewardshi. p Coordinator Clinical Pharmacist. Cape Fear Valley Health. start@capefearvalley.com. . I have no relevant financial relationships with the manufacturers of any of the products discussed in this CE activity. Opening comments. BILLY MCDOWELL. . Studies in Process. -Sample Device Bias. -Audio Hybrid White Paper. -Literature Review for next wave Landscape Measurement. . Studies in Review. -Big Data Advanced Online Targeting. Clostridium difficile Infection (CDI) Guideline Update: Understanding the Data Behind the Recommendations Erik R. Dubberke, MD, MSPH Associate Professor of Medicine Washington University School of Medicine A case for CCG action. Clinical Commissioning Group (CCG). slide deck – prepared . 18. /12/2015. Background. Public Health England supports . a new programme of work on tackling high blood . pressure. Prior studies show that 3 - 26% of hospitalized patients are asymptomatically colonized with C. difficile . Available assays are not able to distinguish between C. difficile infection and coloniz updated. . Clostridium . Difficile. Prevention Primer . is available . at . http://. www.cdc.gov/hai/pdfs/toolkits/CDI-Primer-2-2016.pdf. Clostridioides. Difficile. Infection. Levi Teigen, PhD, RD. May 11, 2021. Objectives. Recognize the nutritional implications of a . C. difficile . infection at both a systemic and local (i.e. colonic) level. Rupert Clarke. Chairman PIA Long-term Value . Group. Managing Partner, Lipton Rogers Developments. February 2019. The Property Market is Cyclical. . CRE Index Capital Value Trend line – Inflation .